FinCanna Capital Corp (TSE:CALI.X)
CNQX:CALI.X

FinCanna Capital Corp (CALI.X) Stock Price & Analysis

6 Followers

CALI.X Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week Range― - ―
Previous CloseC$0.01
Volume9.00K
Average Volume (3M)N/A
Market Cap
C$4.48M
Enterprise ValueC$7.33M
Total Cash (Recent Filing)C$79.42K
Total Debt (Recent Filing)C$2.93M
Price to Earnings (P/E)
Beta1.76
Aug 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding996,005,671
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.00
R-Squared1.00
Alpha0.00
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

25.12%0.00%0.00%74.88%
25.12% Insiders
0.00% Other Institutional Investors
74.88% Public Companies and
Individual Investors

CALI.X FAQ

What was FinCanna Capital Corp’s price range in the past 12 months?
Currently, no data Available
What is FinCanna Capital Corp’s market cap?
Currently, no data Available
When is FinCanna Capital Corp’s upcoming earnings report date?
FinCanna Capital Corp’s upcoming earnings report date is Aug 26, 2024 which is in 32 days.
    How were FinCanna Capital Corp’s earnings last quarter?
    FinCanna Capital Corp released its earnings results on Mar 28, 2024. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
      Is FinCanna Capital Corp overvalued?
      According to Wall Street analysts FinCanna Capital Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does FinCanna Capital Corp pay dividends?
        FinCanna Capital Corp does not currently pay dividends.
        What is FinCanna Capital Corp’s EPS estimate?
        FinCanna Capital Corp’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does FinCanna Capital Corp have?
        FinCanna Capital Corp has 895,347,900 shares outstanding.
          What happened to FinCanna Capital Corp’s price movement after its last earnings report?
          FinCanna Capital Corp reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of FinCanna Capital Corp?
            Currently, no hedge funds are holding shares in TSE:CALI.X
            ---

            FinCanna Capital Corp Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -46.60%
            Trailing 12-Months

            Company Description

            FinCanna Capital Corp

            FinCanna Capital Corp is a Canada based royalty investment company for licensed medical cannabis. The organization operates in one business segment, being a financier of companies operating in the cannabis sector located in the United States.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            CTT Pharmaceutical Holdings
            Nouveau Life Pharmaceuticals
            Manzo Pharmaceuticals
            CannTrust Holdings
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis